Effect of Hijikia fusiforme extracts on degenerative osteoarthritis in vitro and in vivo models
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: The inhibitory effect of Hijikia fusiforme (HF) extracts on degenerative osteoarthritis was examined in primary cultured rat cartilage cells and a monosodium iodoacetate (MIA)-induced osteoarthritis rat model. MATERIALS/METHODS: In vitro, cell survival and the expression of matrix metalloproteinases (MMPs), collagen type I, collagen type II, aggrecan, and tissue inhibitor of metalloproteinases (TIMPs) was measured after H2O2 (800 μM, 2 hr) treatment in primary chondrocytes. In vivo animal study, osteoarthritis was induced by intra-articular injection of MIA into knee joints of rats, and then RH500, HFE250 and HFE500 were administered orally once a day for 28 days. To determine the anti-inflammatory effects of HFE, nitric oxide (NO), prostaglandin E2 (PGE2) expression were measured. In addition, real-time PCR was performed to measure the genetic expression of MMPs, collagen type I, collagen type II, aggrecan, and TIMPs. RESULTS: In the in vitro assay, cell survival after H2O2 treatment was increased by HFE extract (20% EtOH). In addition, anabolic factors (genetic expression of collagen type I, II, and aggrecan) were increased by HFE extract (20% EtOH). However, the genetic expression of MMP-3 and 7, known as catabolic factors were significantly inhibited by treatment with HFE extract (20% EtOH). In the in vivo assay, anabolic factors (genetic expression of collagen type I, II, aggrecan, and TIMPs) were increased by oral administration of HFE extract. However, the genetic expression of MMP-3 and 7, known as catabolic factors, and production of NO and PGE2 were significantly inhibited by treatment with oral administration of HFE extract. CONCLUSION: HFE extract inhibited articular cartilage degeneration through preventing extracellular matrix degradation and chondrocyte injury.
Abstract
BACKGROUND/OBJECTIVES: The inhibitory effect of Hijikia fusiforme (HF) extracts on degenerative osteoarthritis was examined in primary cultured rat cartilage cells and a monosodium iodoacetate (MIA)-induced osteoarthritis rat model. MATERIALS/METHODS: In vitro, cell survival and the expression of matrix metalloproteinases (MMPs), collagen type I, collagen type II, aggrecan, and tissue inhibitor of metalloproteinases (TIMPs) was measured after H2O2 (800 μM, 2 hr) treatment in primary chondrocytes. In vivo animal study, osteoarthritis was induced by intra-articular injection of MIA into knee joints of rats, and then RH500, HFE250 and HFE500 were administered orally once a day for 28 days. To determine the anti-inflammatory effects of HFE, nitric oxide (NO), prostaglandin E2 (PGE2) expression were measured. In addition, real-time PCR was performed to measure the genetic expression of MMPs, collagen type I, collagen type II, aggrecan, and TIMPs. RESULTS: In the in vitro assay, cell survival after H2O2 treatment was increased by HFE extract (20% EtOH). In addition, anabolic factors (genetic expression of collagen type I, II, and aggrecan) were increased by HFE extract (20% EtOH). However, the genetic expression of MMP-3 and 7, known as catabolic factors were significantly inhibited by treatment with HFE extract (20% EtOH). In the in vivo assay, anabolic factors (genetic expression of collagen type I, II, aggrecan, and TIMPs) were increased by oral administration of HFE extract. However, the genetic expression of MMP-3 and 7, known as catabolic factors, and production of NO and PGE2 were significantly inhibited by treatment with oral administration of HFE extract. CONCLUSION: HFE extract inhibited articular cartilage degeneration through preventing extracellular matrix degradation and chondrocyte injury.
참고문헌 (29)
- Korea Health Statistics 2012: Korea National Health and Nutrition Examination Survey, "Ministry of Health and Welfare", Korea Centers for Disease Control and Prevention, ~, pp.KNHANES V-3 (2013)
- Senior Statistical Reports, "Statistics Korea", Statistics Korea, ~ (2010)
- Garner BC, "Using animal models in osteoarthritis biomarker research", J Knee Surg, 24, pp.251~264 (2011)
- 남다은, "보스웰리아 추출물의 골관절염 억제 효과 연구", 한국식품영양과학회지, 43(5), pp.631~640 (2014), 한국식품영양과학회
- Lee JH, "Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression", Arthritis Rheum, 52, pp.2386~2395 (2005)
- Roy S, "Regulation of vascular responses to inflammation:inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia", Antioxid Redox Signal, 8, pp.653~660 (2006)
- Lee V, "The roles of matrix molecules in mediating chondrocyte aggregation, attachment, and spreading", J Cell Biochem, 79, pp.322~333 (2000)
- Health Functional Food Industry Development Assistance Report 2011, "Korea Health Industry Development Institute", Korea Health Industry Development Institute, ~ (2011)
- 전민희, "톳 분획물이 조골세포의 증식 및 분화에 미치는 영향", 생명과학회지, 21(2), pp.300~308 (2011), 한국생명과학회
- 김진아, "건조방법에 따른 해조류(톳)의 생리활성 성분 및 항산화 활성의 변화", 한국식생활문화학회지, 19(2), pp.200~208 (2004), 한국식생활문화학회
- Kapoor M, "Role of proinflammatory cytokines in the pathophysiology of osteoarthritis", Nat Rev Rheumatol, 7, pp.33~42 (2011)
- Development of Instant Health Foods Using Hijiki, "Ministry for Food, Agriculture, Forestry and Fisheries", Ministry for Food, Agriculture, Forestry and Fisheries, ~ (1997)
- Watanabe T, "Toxicological evaluation of arsenic in edible seaweed, Hizikia species", Toxicology, 14, pp.1~22 (1979)
- Dobashi K, "Isolation and preliminary characterization of fucose-containing sulfated polysaccharides with blood-anticoagulant activity from the brown seaweed Hizikia fusiforme", Carbohydr Res, 194, pp.315~320 (1989)
- Holan ZR, "Biosorption of lead and nickel by biomass of marine algae", Biotechnol Bioeng, 43, pp.1001~1009 (1994)
- Jeong SC, "Immune-modulating activities of polysaccharides extracted from brown algae Hizikia fusiforme", Biosci Biotechnol Biochem, 79, pp.1362~1365 (2015)
- Mathy-Hartert M, "Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes", Inflamm Res, 52, pp.111~118 (2003)
- Asada S, "Effect of hydrogen peroxide on the metabolism of articular chondrocytes", Inflamm Res, 48, pp.399~403 (1999)
- Khan IM, "Oxidative stress induces expression of osteoarthritis markers procollagen IIA and 3B3(-) in adult bovine articular cartilage", Osteoarthritis Cartilage, 16, pp.698~707 (2008)
- Catrina AI, "Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept)down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis", Rheumatology (Oxford), 41, pp.484~489 (2002)
- Houssiau FA, "Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides", Arthritis Rheum, 31, pp.784~788 (1988)
- Tchetverikov I, "MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis", Ann Rheum Dis, 64, pp.694~698 (2005)
- Wink DA, "Nitric oxide and redox mechanisms in the immune response", J Leukoc Biol, 89, pp.873~891 (2011)
- Thomas CM, "Chondrocyte death by apoptosis is associated with the initiation and severity of articular cartilage degradation", Int J Rheum Dis, 14, pp.191~198 (2011)
- Vane JR, "Cyclooxygenases 1 and 2", Annu Rev Pharmacol Toxicol, 38, pp.97~120 (1998)
- Bensen WG, "Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial", Mayo Clin Proc, 74, pp.1095~1105 (1999)
- Hardy MM, "Cyclooxygenase 2-dependent prostaglandin E2modulates cartilage proteoglycan degradation in human osteoarthritis explants", Arthritis Rheum, 46, pp.1789~1803 (2002)
- Combe R, "The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats?", Neurosci Lett, 370, pp.236~240 (2004)
- Kim MJ, "Anti-inflammatory effects of 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone via NF-κB inactivation in lipopolysaccharide-stimulated RAW 264.7 macrophage", Mol Med Rep, 9, pp.1197~1203 (2014)